Found 22 matching trials
A Phase I Study of GFH312 in Healthy Chinese Subjects
PHASE1The aim of this study was to evaluate the pharmacokinetic profile and obser...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets
PHASE1This phase I clinical study is a phase I clinical study on the safety, tole...
Location
The first hospital of Jilin University
Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults
PHASE1The goal of this clinical trial is to evaluate the safety, tolerability, an...
Status
Enrolling By Invitation
Location
The first hospital of Lanzhou University
A Trial to Evaluate KPC000154 Tablets in Healthy Subjects
PHASE1A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokine...
Location
No.49, Huayuan North Road, Haidian District, Beijing City
Study to Evaluate IMG-004 in Healthy Participants
PHASE1A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Orally Adm...
A Phase I Study of SHEN26 Capsule in Healthy Participants
PHASE1This is a randomized, double-blind, and placebo-controlled phase I clinical...
Location
The Second Hospital of Anhui Medical University
Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
PHASE1A Phase 1, Partially Blind, Placebo Controlled, Randomized, Combined Single...
Location
Worldwide Clinical Trials
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
PHASE1The purpose of the study is to evaluate the safety, tolerability, pharmacok...
Location
Sun Yat-sen University Cancer Center
EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients
PHASE1This randomized, double-blind study will assess the safety, pharmacokinetic...
Location
Auckland Clinical Studies Ltd
A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis
PHASE1This trial is a phase 1, randomized, double-blind, placebo-controlled trial...
Location
The First Hospital of China Medical University